RxSight (NASDAQ:RXST) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.33) by 90.96 percent. This is a 200 percent decrease over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $32.607 million which beat the analyst consensus estimate of $30.117 million by 8.27 percent. This is a 18.92 percent decrease over sales of $40.214 million the same period last year.